发明授权
- 专利标题: MULTIPLE UNIT PHARMACEUTICAL FORMULATION
- 专利标题(中): 多单位药物制剂
-
申请号: EP07736412.3申请日: 2007-06-03
-
公开(公告)号: EP2026768B1公开(公告)日: 2018-02-28
- 发明人: PENHASI, Adel , MOSES-HELLER, Sheera , GOMBERG, Mila , AVRAMOFF, Avi
- 申请人: Dexcel Pharma Technologies Ltd.
- 申请人地址: P.O. Box 50 38100 Hadera IL
- 专利权人: Dexcel Pharma Technologies Ltd.
- 当前专利权人: Dexcel Pharma Technologies Ltd.
- 当前专利权人地址: P.O. Box 50 38100 Hadera IL
- 代理机构: Becker Kurig Straus
- 优先权: US809942P 20060601
- 国际公布: WO2007138606 20071206
- 主分类号: A61K9/20
- IPC分类号: A61K9/20 ; A61K9/50 ; A61K31/4439
摘要:
An orally disintegratable benzimidazole formulation, featuring a plurality of compressed pellets in a MUPS tablet. The individual units feature a substrate with the active ingredient and an enteric coating, optionally with a subcoating between the substrate and the enteric coating. The individual units are preferably at least partially coated with an outer coating which features a stress absorber, thereby enabling the pellets to be compressed without disturbing the integrity of the enteric coating. The enteric coating preferably does not feature a plasticizer.
公开/授权文献
- EP2026768A2 MULTIPLE UNIT PHARMACEUTICAL FORMULATION 公开/授权日:2009-02-25
信息查询